Biotech · Private company
Perfuse Therapeutics, Inc.
Track this companyFree. Adds Perfuse Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- PER-001 Intravitreal Implant - High DosePhase 2 · Diabetic RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- PER-001 Intravitreal Implant - High DosePhase 2 · Open-angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- PER-001 Intravitreal Implant - Low DosePhase 2 · Diabetic RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- PER-001 Intravitreal Implant - Low DosePhase 2 · Open-angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- PER-001 Intravitreal Implant - ShamPhase 2 · Diabetic RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- PER-001 Intravitreal Implant - ShamPhase 2 · Open-angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of PER-001 in Participants With Diabetic RetinopathyPHASE2 · COMPLETED · started Aug 5, 2023ClinicalTrials.gov NCT06003751 · fetched Nov 12, 2026
- A Study of PER-001 in Participants With Open-Angle GlaucomaPHASE1_PHASE2 · COMPLETED · started May 25, 2023ClinicalTrials.gov NCT05822245 · fetched Nov 12, 2026